A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

The requested reference [eb66ac4a587b7649e60f88af04627c7eccb318f0] no longer exists in our database. It has been replaced by the current reference: [2c872b6772fe0e3c99ff9d9f8e220abe9b38efe1]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared to tirzepatide for body weight reduction in participants with obesity or overweight and type 2 diabetes. Participation in the study will last about 2 years.
Epistemonikos ID: 89bedf787248ab440547fad37fa310de6986188d
First added on: Oct 20, 2026